PARP Combination Therapies: A New Horizon in Prostate Cancer Care

Gain expert insight on the evolving role of PARP inhibitor therapy including in combination with AR-targeting agents for the treatment of advanced prostate cancer by watching an on-demand webcast of a live symposium downloading the accompanying slidesets and reading a commentary of FAQs from the symposium.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.

Pfizer, Inc.